Literature DB >> 27715657

Self-gated Non-Contrast-enhanced Functional Lung MR Imaging for Quantitative Ventilation Assessment in Patients with Cystic Fibrosis.

Simon Veldhoen1, Andreas M Weng1, Janine Knapp1, Andreas S Kunz1, Daniel Stäb1, Clemens Wirth1, Florian Segerer1, Helge Hebestreit1, Uwe Malzahn1, Herbert Köstler1, Thorsten A Bley1.   

Abstract

Purpose To assess the clinical feasibility of self-gated non-contrast-enhanced functional lung (SENCEFUL) magnetic resonance (MR) imaging for quantitative ventilation (QV) imaging in patients with cystic fibrosis (CF). Materials and Methods Twenty patients with CF and 20 matched healthy volunteers underwent functional 1.5-T lung MR imaging with the SENCEFUL imaging approach, in which a two-dimensional fast low-angle shot sequence is used with quasi-random sampling. The lungs were manually segmented on the ventilation-weighted images to obtain QV measurements, which were compared between groups. QV values of the patients were correlated with results of pulmonary function testing. Three radiologists rated the images for presence of ventilation deficits by means of visual inspection. Mann-Whitney U tests, receiver operating characteristic analyses, Spearman correlations, and Gwet agreement coefficient analyses were used for statistical analysis. Results QV of the entire lungs was lower for patients with CF than for control subjects (mean ± standard deviation, 0.09 mL/mL ± 0.03 vs 0.11 mL/mL ± 0.03, respectively; P = .007). QV ratios of upper to lower lung halves were lower in patients with CF than in control subjects (right, 0.84 ± 0.2 vs 1.16 ± 0.2, respectively [P < .001]; left, 0.88 ± 0.3 vs 1.11 ± 0.1, respectively [P = .017]). Accordingly, ventilation differences between the groups were larger in the upper halves (Δ = 0.04 mL/mL, P ≤ .001-.002). QV values of patients with CF correlated with forced vital capacity (r = 0.7; 95% confidence interval [CI]: 0.21, 0.91), residual volume (static hyperinflation, r = -0.8; 95% CI: -0.94, 0.42), and forced expiratory volume in 1 second (airway obstruction, r = 0.7; 95% CI: 0.21, 0.91). Disseminated small ventilation deficits were the most frequent involvement pattern, present in 40% of the functional maps in CF versus 8% in the control subjects (P < .001). Conclusion SENCEFUL MR imaging is feasible for QV assessment. Less QV, especially in upper lung parts, and correlation to vital capacity and to markers for hyperinflation and airway obstruction were found in patients with CF. © RSNA, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27715657     DOI: 10.1148/radiol.2016160355

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

2.  New severity assessment in cystic fibrosis: signal intensity and lung volume compared to LCI and FEV1: preliminary results.

Authors:  Sabrina Fleischer; Mareen Sarah Kraus; Sergios Gatidis; Winfried Baden; Andreas Hector; Dominik Hartl; Ilias Tsiflikas; Juergen Frank Schaefer
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

3.  Functional MRI of the Lungs Using Single Breath-Hold and Self-Navigated Ultrashort Echo Time Sequences.

Authors:  Julius F Heidenreich; Simon Veldhoen; Corona Metz; Lenon Mendes Pereira; Thomas Benkert; Josef Pfeuffer; Thorsten A Bley; Herbert Köstler; Andreas M Weng
Journal:  Radiol Cardiothorac Imaging       Date:  2020-06-25

4.  Simultaneous Evaluation of Lung Anatomy and Ventilation Using 4D Respiratory-Motion-Resolved Ultrashort Echo Time Sparse MRI.

Authors:  Li Feng; Jean Delacoste; David Smith; Joseph Weissbrot; Eric Flagg; William H Moore; Francis Girvin; Roy Raad; Priya Bhattacharji; David Stoffel; Davide Piccini; Matthias Stuber; Daniel K Sodickson; Ricardo Otazo; Hersh Chandarana
Journal:  J Magn Reson Imaging       Date:  2018-09-25       Impact factor: 4.813

Review 5.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

Review 6.  Novel imaging techniques for cystic fibrosis lung disease.

Authors:  Jennifer L Goralski; Neil J Stewart; Jason C Woods
Journal:  Pediatr Pulmonol       Date:  2021-02

7.  Homogeneity score test of AC1 statistics and estimation of common AC1 in multiple or stratified inter-rater agreement studies.

Authors:  Chikara Honda; Tetsuji Ohyama
Journal:  BMC Med Res Methodol       Date:  2020-02-05       Impact factor: 4.615

Review 8.  Imaging of Airway Obstruction in Children.

Authors:  Derek J Roebuck; Conor Murray; Clare A McLaren
Journal:  Front Pediatr       Date:  2020-11-11       Impact factor: 3.418

9.  Defect distribution index: A novel metric for functional lung MRI in cystic fibrosis.

Authors:  Anne Valk; Corin Willers; Kamal Shahim; Orso Pusterla; Grzegorz Bauman; Robin Sandkühler; Oliver Bieri; Florian Wyler; Philipp Latzin
Journal:  Magn Reson Med       Date:  2021-08-02       Impact factor: 3.737

Review 10.  Fibrosis imaging: Current concepts and future directions.

Authors:  Maike Baues; Anshuman Dasgupta; Josef Ehling; Jai Prakash; Peter Boor; Frank Tacke; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-11-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.